Tender detail
Joint procurement of medicinal products containing glecaprevir and pibrentasvir 2026
Summary
Olomouc University Hospital and Ostrava University Hospital are jointly procuring recurring supplies of medicinal products containing the active substances glecaprevir and pibrentasvir. The products must meet the requirements of the Czech State Institute for Drug Control. The estimated contract value is CZK 64,934,100, and the planned contract period is 48 months.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.